SVNS — Solvonis Therapeutics Share News
0.000.00%
Last trade - 00:00- £3.50m
- £2.74m
- 24
- 22
- 43
- 17
REG - Solvonis Therapeutic - Proposed acquisition of Awakn approved
AnnouncementREG - Solvonis Therapeutic - Final Results for the year ended 31 December 2024
AnnouncementREG - Solvonis Therapeutic - Posting of Circular and Notice of General Meeting
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Engagement of PharmaVentures
AnnouncementREG - Solvonis Therapeutic - Positive progress on European Patent Application
AnnouncementREG - Solvonis Therapeutic - Update on AWKN-SDN-14 programme
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Appointment of Non-Executive Director
AnnouncementRCS - Solvonis Therapeutic - Presentation at PharmaSynergyRx Event
AnnouncementREG - Solvonis Therapeutic - Entry into an Arrangement Agreement with Awakn
AnnouncementRCS - Solvonis Therapeutic - Proactive Investors interview with Chairman
AnnouncementREG - Solvonis Therapeutic - Update on Awakn Life Sciences’ R&D Progress
AnnouncementRCS - Solvonis Therapeutic - Investor Presentation
AnnouncementRCS - Solvonis Therapeutic - Proactive Investors interview with CEO
AnnouncementREG - Solvonis Therapeutic - Update on FDA Pre-IND Meeting for Awakn
Announcement